Report cover image

Neoantigen Targeted Therapies Global Market Report 2023 Including: 1) By Type: Monotherapy; Combination Therapy 2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies 3) By Target Disease

Publisher The Business Research Company
Published Sep 21, 2023
Length 175 Pages
SKU # BRC18193074

Description

Neoantigen Targeted Therapies Global Market Report 2023

Including: 1) By Type: Monotherapy; Combination Therapy2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company


Neoantigen Targeted Therapies Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neoantigen targeted therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for neoantigen targeted therapies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neoantigen targeted therapies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Type: Monotherapy; Combination Therapy

2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies

3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer

4) By Route of Administration: Intradermal; Intravenous; Subcutaneous

5) By Application: Medical Research Institution; Hospital; and Clinic; Other Applications

Companies Mentioned: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Neoantigen Targeted Therapies Market Characteristics
3. Neoantigen Targeted Therapies Market Trends And Strategies
4. Neoantigen Targeted Therapies Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Neoantigen Targeted Therapies Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Neoantigen Targeted Therapies Market Segmentation
6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Monotherapy
Combination Therapy
6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
DNA Or RNA-Based Vaccines
Protein-Based Vaccines
Dendritic Cell Vaccines
TIL-Based Therapies
6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Bone Cancer
Gynecological Cancer
6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Intradermal
Intravenous
Subcutaneous
6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Medical Research Institution
Hospital And Clinic
Other Applications
7. Neoantigen Targeted Therapies Market Regional And Country Analysis
7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Neoantigen Targeted Therapies Market
8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Neoantigen Targeted Therapies Market
9.1. China Neoantigen Targeted Therapies Market Overview
9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Neoantigen Targeted Therapies Market
10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Neoantigen Targeted Therapies Market
11.1. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Neoantigen Targeted Therapies Market
12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Neoantigen Targeted Therapies Market
13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Neoantigen Targeted Therapies Market
14.1. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Neoantigen Targeted Therapies Market
15.1. Western Europe Neoantigen Targeted Therapies Market Overview
15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Neoantigen Targeted Therapies Market
16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Neoantigen Targeted Therapies Market
17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Neoantigen Targeted Therapies Market
18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Neoantigen Targeted Therapies Market
19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Neoantigen Targeted Therapies Market
20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Neoantigen Targeted Therapies Market
21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview
21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Neoantigen Targeted Therapies Market
22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Neoantigen Targeted Therapies Market
23.1. North America Neoantigen Targeted Therapies Market Overview
23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Neoantigen Targeted Therapies Market
24.1. USA Neoantigen Targeted Therapies Market Overview
24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Neoantigen Targeted Therapies Market
25.1. Canada Neoantigen Targeted Therapies Market Overview
25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Neoantigen Targeted Therapies Market
26.1. South America Neoantigen Targeted Therapies Market Overview
26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Neoantigen Targeted Therapies Market
27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Neoantigen Targeted Therapies Market
28.1. Middle East Neoantigen Targeted Therapies Market Overview
28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Neoantigen Targeted Therapies Market
29.1. Africa Neoantigen Targeted Therapies Market Overview
29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles
30.1. Neoantigen Targeted Therapies Market Competitive Landscape
30.2. Neoantigen Targeted Therapies Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Merck and Co. Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Bristol Myers Squibb Company
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. GlaxoSmithKline plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Eli Lilly and Company
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies
31.1. Kite Pharma Inc.
31.2. Gilead Sciences Inc.
31.3. Amgen Inc.
31.4. Moderna Inc.
31.5. BioNTech SE
31.6. Bavarian Nordic Inc.
31.7. Advaxis Inc.
31.8. Immatics NV
31.9. Precision Biologics Inc.
31.10. Iovance Biotherapeutics Inc.
31.11. Agenus Inc.
31.12. Achilles Therapeutics Plc
31.13. Medigene AG
31.14. Gritstone Bio Inc.
31.15. SQZ Biotechnologies Company
32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking
33. Global Neoantigen Targeted Therapies Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market
35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis
35.1 Neoantigen Targeted Therapies Market In 2027 - Countries Offering Most New Opportunities
35.2 Neoantigen Targeted Therapies Market In 2027 - Segments Offering Most New Opportunities
35.3 Neoantigen Targeted Therapies Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us